The US Food and Drug Administration's authorisation of Purdue's controlled-release methylphenidate for adult ADHD: comments on the regulatory practice.

ABSTRACT:

SUBMITTER: Boesen K 

PROVIDER: S-EPMC8361378 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature